Tela Bio slumps after Q4 miss as Piper Sandler downgrades
Shares of Tela Bio (NASDAQ:TELA) plunged in the morning hours on Friday after the maker of OviTex surgical mesh fell short of ...
Tela Bio price target lowered to $6 from $8 at Lake Street, buy on weakness
Lake Street lowered the firm’s price target on Tela Bio (TELA) to $6 from $8 and keeps a Buy rating on the shares. Tela Bio’s Q4 results were ...
Tela Bio price target lowered to $7 from $12 at Citizens JMP
Citizens JMP lowered the firm’s price target on Tela Bio (TELA) to $7 from $12 and keeps an Outperform rating on the shares. Sales in the ...
manilatimes24d
TELA Bio to Announce Fourth Quarter and Full Year 2024 Financial Results
MALVERN, Pa., Feb. 27, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction ...